您当前的位置：

Desfesoterodine

(Synonyms: (R)-5-羟甲基托特罗定; PNU-200577; 5-Hydroxymethyl Tolterodine)

目录号: PL06858 纯度: ≥98%

Desfesoterodine (PNU-200577) 是一种有效的，选择性毒蕈碱受体 (mAChR) 拮抗剂，KB 和 pA2 分别为 0.84 nM 和 9.14。Desfesoterodine 是 Tolterodine (PNU-200583; HY-A0024) 和 Fesoterodine (HY-70053) 的主要药理活性代谢产物。Desfesoterodine 改善大鼠脑梗死诱导膀胱过度活动。

CAS No. :207679-81-0

商品编号	规格	价格	会员价
PL06858-5mg	5mg	¥1185.00	请登录
PL06858-10mg	10mg	¥1845.00	请登录
PL06858-50mg	50mg	¥4585.00	请登录
PL06858-100mg	100mg	¥6485.00	请登录
PL06858-200mg	200mg	¥8745.00	请登录
PL06858-500mg	500mg	询价	询价
PL06858-10mM*1mLinDMSO	10mM*1mLinDMSO	¥2545.00	请登录
PL06858-1 mL x 10 mM (in DMSO)		¥891.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!

加入购物车在线咨询收藏产品大包装询价

中文名称	Desfesoterodine
中文别名	(R)-5-羟甲基托特罗定;(R)5 - 羟基甲基托特罗定标准品;1,1’-[(4-甲基苯基)亚氨基]二-2-丙醇;3-[(1R)-3-[双(1-甲基乙基)氨基]-1-苯基丙基]-4-羟基苯甲醇
英文名称	Desfesoterodine
英文别名	(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol;3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxybenzenemethanol;5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM);(R)-5-HYDROXYMETHYL TOLTERODINE;3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-Benzenemethanol;5-hydroxymethyl Tolterodine;R-(+)-2(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol;Desfesoterodine;PNU 200577;PNU-200577
Cas No.	207679-81-0
分子式	C₂₂H₃₁NO₂
分子量	341.49
包装储存	Powder -20°C 3 years；4°C 2 years
详情描述	Desfesoterodine (PNU-200577) 是一种有效的，选择性毒蕈碱受体 (mAChR) 拮抗剂，KB 和 pA2 分别为 0.84 nM 和 9.14。Desfesoterodine 是 Tolterodine (PNU-200583; HY-A0024) 和 Fesoterodine (HY-70053) 的主要药理活性代谢产物。Desfesoterodine 改善大鼠脑梗死诱导膀胱过度活动。

产品详情	Desfesoterodine (PNU-200577) 是一种有效的，选择性毒蕈碱受体 (mAChR) 拮抗剂，K_B 和 pA₂ 分别为 0.84 nM 和 9.14。Desfesoterodine 是 Tolterodine (PNU-200583; HY-A0024) 和 Fesoterodine (HY-70053) 的主要药理活性代谢产物。Desfesoterodine 改善大鼠脑梗死诱导膀胱过度活动。
生物活性	Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a K B and a pA 2 of 0.84 nM and 9.14, respectively. Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053). Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats.
性状	Solid
IC50 & Target[1][2]	Kb: 0.84 nM (mAChR).
体外研究(In Vitro)	In vitro, Desfesoterodine preventes carbachol-induced contraction of guinea-pig isolated urinary bladder strips in a competitive and concentration-dependent manner. In radioligand binding studies carries out in homogenates of guinea-pig tissues and Chinese hamster ovary cell lines expressing human muscarinic m1-m5 receptors, Desfesoterodine is not selective for any muscarinic receptor subtype. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	Desfesoterodine (PNU-200577; 5-Hydroxymethyl Tolterodine; 0.1 and 1 mg/kg; IV) significantly increases bladder compliance after moderate and high doses. In vivo, Desfesoterodine is significantly more potent at suppressing acetylcholine-induced urinary bladder contraction than electrically induced salivation in the anaesthetised cat (ID50=15 and 40 nmol/kg, respectively) . has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Nilvebrant L, Gillberg PG, Sparf B. Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine. Pharmacol Toxicol. 1997 Oct;81(4):169-72. [2]. Fullhase, Claudius; Soler, Roberto; Gratzke, Christian et al. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction. Journal of Urology (New York, NY, United States)

溶解度数据	In Vitro: H₂O : 100 mg/mL (292.83 mM; Need ultrasonic)DMSO : 50 mg/mL (146.42 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

[1]. Nilvebrant L, Gillberg PG, Sparf B. Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine. Pharmacol Toxicol. 1997 Oct;81(4):169-72.
[2]. Fullhase, Claudius; Soler, Roberto; Gratzke, Christian et al. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction. Journal of Urology (New York, NY, United States)

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

Desfesoterodine

相关产品

The molarity calculator equation

The dilution calculator equation